is saxenda a glp 1 First Generic GLP-1 Injection OK'd for Weight Loss Wegovy and Saxenda: 2 GLP-1

Much like managing insulin therapy from a Read More GLP-1 Therapy Discontinuation: How to Identify Patients at Risk and Prevent Drop-Off May 5, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 971 views Discontinuation of GLP-1 therapy is becoming a growing concern in diabetes care, even though these treatments show strong clinical benefits

This is risky and not recommended, as compounded GLP-1 medications are linked to cases of hospitalizations , the FDA warns

Preprint at bioRxiv (2023)

Regular vital sign checks at follow-up appointments were sufficient to identify concerning trends

Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: a randomised, open-label phase II trial

For patients seeking safe and effective treatment, this creates a landscape of fear and uncertainty